Skip to content

Virtual Reality in Reducing Acute Orthopedic Pain

Virtual Reality in Reducing Acute Orthopedic Pain

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06624969
Enrollment
100
Registered
2024-10-03
Start date
2026-04-23
Completion date
2028-12-01
Last updated
2026-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fractures

Keywords

pain control, orthopedic, fracture, hospital

Brief summary

The primary aim of this research is to show that a virtual reality (VR) service line is feasible and can sustain itself with the ability to take care of patients. Additionally, the investigators aim to learn about the limitations of a service line and provide a pathway for future improvements in building a VR service line that is optimally aligned with the user's needs. Secondary aims are to evaluate the clinical aspects of the patient's outcomes including length of stay, morphine equivalents in pain medicine required during the hospital stay, and user experiences.

Interventions

OTHERvirtual reality

Virtual reality program to reduce pain in orthopedic fractures

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Hospitalized with an orthopedic fracture 2. Able to participate fully in all aspects of the study 3. Able to understand and sign informed consent 4. Individuals with unaided vision or those who can correct their vision using contact lenses

Exclusion criteria

5. Non-English speaking 6. Self-reported history of acute and/or chronic severe motion sickness 7. The presence of a facial/head deformity that will prohibit the wearing of a VR head mounted display. 8. Legally blind or deaf 9. Have had a seizure within the past 1 year 10. Have current (within the past 30 days) clinically significant acute or chronic progressive or unstable/uncontrolled neurologic disorder 11. Have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence

Design outcomes

Primary

MeasureTime frameDescription
opioid useFrom date of enrollment which begins at hospital admission until the date of hospital discharge, assessed up to 5 weeksChange in opioid equivalents during hospital stay from hospital admission to discharge

Secondary

MeasureTime frameDescription
reduction in anxiolyticsFrom date of enrollment which begins at hospital admission until the date of hospital discharge, assessed up to 5 weeksChange in anxiolytics during the hospital admission from admission to discharge
hospital length of stayFrom date of enrollment which begins at hospital admission until the date of hospital discharge, assessed up to 5 weeks
reduction in sleep aids prescribedFrom date of enrollment which begins at hospital admission until the date of hospital discharge, assessed up to 5 weeksChange in sleep aids prescribed during the hospital stay from hospital admission to discharge
User experiencesobtained once on the day of hospital discharge, up to 5 weeks from study enrollmentSubjective user experiences with the virtual reality program obtained at hospital discharge using a questionnaire with Likert scale answers showing higher scores to have better experiences with the intervention

Countries

United States

Contacts

CONTACTScott Helgeson, MD
helgeson.scott@mayo.edu904-953-2000
PRINCIPAL_INVESTIGATORScott Helgeson, MD

Mayo Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 6, 2026